Related Experiment Videos
Combination of Dietary Fibers From Different Food Origins as a Treatment for Adults With Functional Constipation: A
Alessandro Di Minno1,2, Maria Vittoria Morone1, Daniele Giuseppe Buccato1
1Department of Pharmacy University of Napoli Federico II Naples Italy.
Abstract:
Laxatives are the primary treatment for functional constipation (FC), but they are not always effective and well-tolerated. Dietary fiber can represent a valid alternative. This study aimed to determine whether combining dietary fibers from different origins could be a valuable strategy for FC. Thus, the efficacy of a fiber-based formulation (MNS-36), composed of resistant dextrin from wheat starch (Triticum aestivum L.), pectin, and insoluble fibers from Citrus spp., and oat fibers (Avena sativa L.) was tested in a monocentric, double-blind, randomized, placebo-controlled clinical trial with 54 adults with FC. Participants received two sachets of MNS-36 or a placebo daily for 28 days, with weekly visits and a follow-up. Compared to the placebo group, bowel movements, used as the primary outcome of the study, increased significantly between baseline and week 4 (β = 2.43 ± 0.23, p < 0.001). Similarly, Bristol Stool Form Scale scores significantly improved in the treatment group (p < 0.001), being normalized from week 2 onwards (p ≤ 0.008). In the treatment group, significant reductions were also observed in abdominal bloating (β = 1.21 ± 0.17, p < 0.001), abdominal distension (β = 1.66 ± 0.18, p < 0.001), heaviness (β = 1.39 ± 0.21, p < 0.001), and flatulence (β = 1.51 ± 0.26, p < 0.001), whereas abdominal pain did not differ significantly between groups. No adverse events were reported, and treatment adherence was high. These findings highlight the efficacy of combining soluble and insoluble fibers from different food origins in improving gut function, addressing both symptoms and tolerability, and underscore this strategy as a natural alternative approach to laxatives for managing FC.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This makes...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...